Robert D. Mccuaig
St Lucia
QLD, Australia
QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus.
Journal: PLoS pathogens
Published: December 13, 2024
In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting.
Journal: Nature communications
Published: August 15, 2022
A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED).
Journal: Frontiers in oncology
Published: January 25, 2022
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication.
Journal: Cell discovery
Published: December 27, 2020
G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 02, 2020
Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch.
Journal: Frontiers in immunology
Published: February 22, 2020
Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Journal: Scientific reports
Published: December 06, 2019
Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: April 30, 2019
Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer.
Journal: Frontiers in immunology
Published: January 11, 2019
Last Updated: 09/26/2026